Cyltezo
Generic Name: cyltezo
Dosage form: LIQUID. Active ingredients: ADALIMUMAB (50 mg/50mg). Category: BULK INGREDIENT.
Overview
Dosage form: LIQUID. Active ingredients: ADALIMUMAB (50 mg/50mg). Category: BULK INGREDIENT.
Dosage
Available as liquid.
Related Medications
Ear/eye/sinus Drops
ear/eye/sinus drops
Non-Standardized Plant Allergenic Extract [EPC]
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Alternaria Tenuis, Aspergillus Mixture, Botrytis Cinerea, Chaetomium Globosum, Cladosporium Cladosporioides, Curvularia, Epicoccum Nigrum, Fusarium Vasinfectum, Mucor Racemosus, Neurospora, Nigrospora, Penicillium Mixture, Phoma Herbarum, Pullularia Pullulans, Rhizopus, Rhodotorula, Stemphylium, Trichoderma Lignorum, Trichophyton Mentagrophytes, Baptisia Tinctoria, Hydrastis Canadensis, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Trigonella Foenum-graecum, Echinacea
alternaria tenuis, aspergillus mixture, botrytis cinerea, chaetomium globosum, cladosporium cladosporioides, curvularia, epicoccum nigrum, fusarium vasinfectum, mucor racemosus, neurospora, nigrospora, penicillium mixture, phoma herbarum, pullularia pullulans, rhizopus, rhodotorula, stemphylium, trichoderma lignorum, trichophyton mentagrophytes, baptisia tinctoria, hydrastis canadensis, myrrha, nasturtium aquaticum, phytolacca decandra, trigonella foenum-graecum, echinacea
Non-Standardized Fungal Allergenic Extract [EPC]
Purpose: Relief from Sneezing, Runny Nose, Itchy Eyes and Sinus Congestion.*
Faricimab
faricimab
11 DESCRIPTION Faricimab-svoa is a humanized bispecific immunoglobulin G1 (IgG1) antibody that binds both vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2). The fragment crystallizable (Fc) region of faricimab was engineered by selected point mutations to abolish binding interactions with Fcγ and FcRn receptors.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.